These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33584287)

  • 1. The Acetylcholine-Activated Potassium Current Inhibitor XAF-1407 Terminates Persistent Atrial Fibrillation in Goats.
    Sobota V; Gatta G; van Hunnik A; van Tuijn I; Kuiper M; Milnes J; Jespersen T; Schotten U; Verheule S
    Front Pharmacol; 2020; 11():608410. PubMed ID: 33584287
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of selective I
    Fenner MF; Carstensen H; Dalgas Nissen S; Melis Hesselkilde E; Scott Lunddahl C; Adler Hess Jensen M; Loft-Andersen AV; Sattler SM; Platonov P; El-Haou S; Jackson C; Tang R; Kirby R; Ford J; Schotten U; Milnes J; Svane Sørensen U; Jespersen T; Buhl R
    Br J Pharmacol; 2020 Aug; 177(16):3778-3794. PubMed ID: 32436234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the acetylcholine-regulated potassium current prevents transient apnea-related atrial arrhythmogenic changes in a porcine model.
    Norup Hertel J; Linz B; Isaksen J; Jerltorp K; Leonhardt C; Gottlieb L; Saljic A; Jespersen T; Linz D
    Heart Rhythm; 2024 May; 21(5):622-629. PubMed ID: 38280622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic effect of vernakalant in electrically remodeled goat atria is caused by slowing of conduction and prolongation of postrepolarization refractoriness.
    van Hunnik A; Lau DH; Zeemering S; Kuiper M; Verheule S; Schotten U
    Heart Rhythm; 2016 Apr; 13(4):964-72. PubMed ID: 26681610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update.
    Tsuji Y; Dobrev D
    Vasc Health Risk Manag; 2013; 9():165-75. PubMed ID: 23637539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective termination of atrial fibrillation by SK channel inhibition is associated with a sudden organization of fibrillatory conduction.
    Gatta G; Sobota V; Citerni C; Diness JG; Sørensen US; Jespersen T; Bentzen BH; Zeemering S; Kuiper M; Verheule S; Schotten U; van Hunnik A
    Europace; 2021 Nov; 23(11):1847-1859. PubMed ID: 34080619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat.
    Blaauw Y; Gögelein H; Tieleman RG; van Hunnik A; Schotten U; Allessie MA
    Circulation; 2004 Sep; 110(13):1717-24. PubMed ID: 15364815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bi-atrial high-density mapping reveals inhibition of wavefront turning and reduction of complex propagation patterns as main antiarrhythmic mechanisms of vernakalant.
    van Hunnik A; Zeemering S; Podziemski P; Kuklik P; Kuiper M; Verheule S; Schotten U
    Europace; 2021 Jul; 23(7):1114-1123. PubMed ID: 33608723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation in the goat induces changes in monophasic action potential and mRNA expression of ion channels involved in repolarization.
    van der Velden HMW ; van der Zee L; Wijffels MC; van Leuven C; Dorland R; Vos MA; Jongsma HJ; Allessie MA
    J Cardiovasc Electrophysiol; 2000 Nov; 11(11):1262-9. PubMed ID: 11083247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic TWIK-Related Acid-Sensitive K+ Channel (TASK-1) Potassium Channel Inhibitor A293 Facilitates Acute Cardioversion of Paroxysmal Atrial Fibrillation in a Porcine Large Animal Model.
    Wiedmann F; Beyersdorf C; Zhou X; Büscher A; Kraft M; Nietfeld J; Walz TP; Unger LA; Loewe A; Schmack B; Ruhparwar A; Karck M; Thomas D; Borggrefe M; Seemann G; Katus HA; Schmidt C
    J Am Heart Assoc; 2020 May; 9(10):e015751. PubMed ID: 32390491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AVE0118, blocker of the transient outward current (I(to)) and ultrarapid delayed rectifier current (I(Kur)), fully restores atrial contractility after cardioversion of atrial fibrillation in the goat.
    de Haan S; Greiser M; Harks E; Blaauw Y; van Hunnik A; Verheule S; Allessie M; Schotten U
    Circulation; 2006 Sep; 114(12):1234-42. PubMed ID: 16940189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Termination of Vernakalant-Resistant Atrial Fibrillation by Inhibition of Small-Conductance Ca
    Diness JG; Skibsbye L; Simó-Vicens R; Santos JL; Lundegaard P; Citerni C; Sauter DRP; Bomholtz SH; Svendsen JH; Olesen SP; Sørensen US; Jespersen T; Grunnet M; Bentzen BH
    Circ Arrhythm Electrophysiol; 2017 Oct; 10(10):e005125. PubMed ID: 29018164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inward rectifier current inhibitor PA-6 terminates atrial fibrillation and does not cause ventricular arrhythmias in goat and dog models.
    Ji Y; Varkevisser R; Opacic D; Bossu A; Kuiper M; Beekman JDM; Yang S; Khan AP; Dobrev D; Voigt N; Wang MZ; Verheule S; Vos MA; van der Heyden MAG
    Br J Pharmacol; 2017 Aug; 174(15):2576-2590. PubMed ID: 28542844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractionation of electrograms and linking of activation during pharmacologic cardioversion of persistent atrial fibrillation in the goat.
    Shan Z; Van Der Voort PH; Blaauw Y; Duytschaever M; Allessie MA
    J Cardiovasc Electrophysiol; 2004 May; 15(5):572-80. PubMed ID: 15149428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Small-Conductance Calcium-Activated Potassium Current (
    Fenner MF; Gatta G; Sattler S; Kuiper M; Hesselkilde EM; Adler DMT; Smerup M; Schotten U; Sørensen U; Diness JG; Jespersen T; Verheule S; Van Hunnik A; Buhl R
    Front Physiol; 2021; 12():614483. PubMed ID: 33633584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of drug-induced and spontaneous cardioversions reveals similar patterns leading to termination of atrial fibrillation.
    van Hunnik A; Sobota V; Zeemering S; Opacic D; Scaf B; D'Alessandro E; Oyaert K; Kuiper M; Diness JG; Sørensen US; Milnes JT; van der Heyden MAG; Jespersen T; Schotten U; Verheule S
    Front Physiol; 2024; 15():1399037. PubMed ID: 39092426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat.
    Blaauw Y; Schotten U; van Hunnik A; Neuberger HR; Allessie MA
    Cardiovasc Res; 2007 Jul; 75(1):89-98. PubMed ID: 17466958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the acetylcholine-regulated inwardly rectifying potassium current a viable antiarrhythmic target? Translational discrepancies of AZD2927 and A7071 in dogs and humans.
    Walfridsson H; Anfinsen OG; Berggren A; Frison L; Jensen S; Linhardt G; Nordkam AC; Sundqvist M; Carlsson L
    Europace; 2015 Mar; 17(3):473-82. PubMed ID: 25082948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Intravenous Vernakalant in Rapid Cardioversion of Recent Onset Atrial Fibrillation: A Retrospective Single-Centre Study.
    Hoteit A; Moumneh MB; Nahlawi A; Hebbo E; Abdulhai F; Abi-Saleh B; Khoury M; Refaat M
    Cureus; 2024 Apr; 16(4):e58616. PubMed ID: 38770450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tertiapin, a selective IKACh blocker, terminates atrial fibrillation with selective atrial effective refractory period prolongation.
    Hashimoto N; Yamashita T; Tsuruzoe N
    Pharmacol Res; 2006 Aug; 54(2):136-41. PubMed ID: 16725344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.